Phase I and early phase II study of PL-AC [N4-palmitoyl-(1-beta-D-arabinofuranosyl) cytosine] on hematopoietic malignancies. 1984

T Takubo, and Y Tani, and Y Kubota, and S Oguma, and T Ueda, and H Nakamura, and H Shibata, and T Masaoka

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females

Related Publications

T Takubo, and Y Tani, and Y Kubota, and S Oguma, and T Ueda, and H Nakamura, and H Shibata, and T Masaoka
February 1983, Gan to kagaku ryoho. Cancer & chemotherapy,
T Takubo, and Y Tani, and Y Kubota, and S Oguma, and T Ueda, and H Nakamura, and H Shibata, and T Masaoka
August 1987, Gan to kagaku ryoho. Cancer & chemotherapy,
T Takubo, and Y Tani, and Y Kubota, and S Oguma, and T Ueda, and H Nakamura, and H Shibata, and T Masaoka
December 1985, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
T Takubo, and Y Tani, and Y Kubota, and S Oguma, and T Ueda, and H Nakamura, and H Shibata, and T Masaoka
April 1988, Gan to kagaku ryoho. Cancer & chemotherapy,
T Takubo, and Y Tani, and Y Kubota, and S Oguma, and T Ueda, and H Nakamura, and H Shibata, and T Masaoka
January 1987, Medical oncology and tumor pharmacotherapy,
T Takubo, and Y Tani, and Y Kubota, and S Oguma, and T Ueda, and H Nakamura, and H Shibata, and T Masaoka
January 1981, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
T Takubo, and Y Tani, and Y Kubota, and S Oguma, and T Ueda, and H Nakamura, and H Shibata, and T Masaoka
May 1992, International journal of cancer,
T Takubo, and Y Tani, and Y Kubota, and S Oguma, and T Ueda, and H Nakamura, and H Shibata, and T Masaoka
June 1987, Japanese journal of clinical oncology,
T Takubo, and Y Tani, and Y Kubota, and S Oguma, and T Ueda, and H Nakamura, and H Shibata, and T Masaoka
January 1971, Clinical pharmacology and therapeutics,
T Takubo, and Y Tani, and Y Kubota, and S Oguma, and T Ueda, and H Nakamura, and H Shibata, and T Masaoka
March 1966, Journal of medicinal chemistry,
Copied contents to your clipboard!